Literature DB >> 1354619

Peripheral hematopoietic stem cell transplantation: current concepts.

P A Lowry1, I A Tabbara.   

Abstract

As methods for increasing stem cells are perfected and alternate regimens for transplantation developed, PSCT will undoubtedly see wider application in combination with BMT and may ultimately replace BMT. The initial encouraging results with PSCT so far portend a major therapeutic role of this modality in the approach to hematologic and oncologic diseases. Prospective randomized trials comparing PSCT and BMT in a variety of clinical settings are needed and are already underway.

Entities:  

Mesh:

Year:  1992        PMID: 1354619

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  4 in total

1.  Efficacy of recombinant human granulocyte-macrophage colony-stimulating factor for chemotherapy-induced leukopenia in patients with non-small-cell lung cancer.

Authors:  K Eguchi; J Kabe; S Kudo; K Mano; H Morinari; K Nakada; K Noda; Y Saito; T Tanaka; T Uzawa
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 2.  Clinical application of allogeneic peripheral blood stem cells transplantation.

Authors:  J Tanaka; M Kasai; M Imamura; M Asaka
Journal:  Ann Hematol       Date:  1995-12       Impact factor: 3.673

3.  Peripheral blood stem cells used to augment autologous bone marrow transplantation.

Authors:  P L Mitchell; V B Shepherd; H M Proctor; M Dainton; S D Cabral; C R Pinkerton
Journal:  Arch Dis Child       Date:  1994-03       Impact factor: 3.791

Review 4.  A comparative review of colony-stimulating factors.

Authors:  J Nemunaitis
Journal:  Drugs       Date:  1997-11       Impact factor: 11.431

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.